Adrenal Gland Neoplasm
NCI Definition: A benign or malignant (primary or metastatic) neoplasm affecting the adrenal glands. 
Adrenal gland neoplasms most frequently harbor alterations in TP53, CTNNB1, CDKN2A, ATRX, and RB1 .
TP53 Mutation, CTNNB1 Mutation, TP53 c.217-c.1178 Missense, TP53 Missense, and ATRX Mutation are the most common alterations in adrenal gland neoplasm .
There is 1 clinical trial for adrenal gland neoplasm, of which 1 is open and 0 are completed or closed. Of the trial that contains adrenal gland neoplasm as an inclusion criterion, 1 is phase 1/phase 2 (1 open).
Bms-986218, nivolumab, and stereotactic body radiation therapy are the most common interventions in adrenal gland neoplasm clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.